Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest in this topic

  1. Evidence for reduced neurogenesis in the aging human hippocampus despite stable stem cell markers 2017-08-01
  2. Altered neurogenesis in Alzheimer's disease 2006-09-01

Studies

2 studies carry this tag.

Date range

2006 to 2017

Top journals

  • Aging cell 1
  • Journal of psychosomatic research 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Evidence for reduced neurogenesis in the aging human hippocampus despite stable stem cell markers

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Aging cell 2017-08-01 Biomarkers

    Reduced neurogenesis in the aging mammalian hippocampus has been linked to cognitive deficits and increased risk of dementia.

  2. Altered neurogenesis in Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Journal of psychosomatic research 2006-09-01 Biomarkers

    The current results indicate a significant reduction of progenitor cells (as labeled by Musashi1) in the SVZ of patients with AD, but an increase in GFAP-negative astrocyte-like cells with progenitor characteristics.

All topic tags with their study counts